An evolutionary explanation for antibiotics' association with increased colon cancer risk
- PMID: 35539898
- PMCID: PMC9081870
- DOI: 10.1093/emph/eoac018
An evolutionary explanation for antibiotics' association with increased colon cancer risk
Abstract
: More than 10 studies have confirmed the association of antibiotic overuse with colorectal cancer. The exact cause is unknown, but most authors hypothesize that disturbance of colon microbiota is the main culprit. In this commentary, an evolutionary explanation is proposed. It is well known that antibiotics can induce antibiotic resistance in bacteria through selection of mutators-DNA mismatch repair deficient (dMMR) strains. Mutators have an increased survival potential due to their high mutagenesis rate. Antibiotics can also cause stress in human cells. Selection of dMMR colon cells may be advantageous under this stress, mimicking selection of bacterial mutators. Concomitantly, mismatch repair deficiency is a common cause of cancer, this may explain the increased cancer risk after multiple cycles of oral antibiotics. This proposed rationale is described in detail, along with supporting evidence from the peer-reviewed literature and suggestions for testing hypothesis validity. Treatment schemes could be re-evaluated, considering toxicity and somatic selection mechanisms.
Lay summary: The association of antibiotics with colon cancer is well established but of unknown cause. Under an evolutionary framework, antibiotics may select for stress-resistant cancerous cells that lack mechanisms for DNA mismatch repair (MMR). This mimics the selection of antibiotic resistant 'mutators'-MMR-deficient micro-organisms-highly adaptive due to their increased mutagenesis rate.
Keywords: DNA repair; MLH1; MSH2; adaptation; cancer evolution; natural selection.
© The Author(s) 2022. Published by Oxford University Press on behalf of the Foundation for Evolution, Medicine, and Public Health.
Figures


Similar articles
-
[Difference analysis of somatic mutations between deficient mismatch repair and proficient mismatch repair gene related with colorectal cancer].Zhonghua Zhong Liu Za Zhi. 2021 Oct 23;43(10):1088-1093. doi: 10.3760/cma.j.cn112152-20190719-00448. Zhonghua Zhong Liu Za Zhi. 2021. PMID: 34695900 Chinese.
-
Interdependence of DNA mismatch repair proteins MLH1 and MSH2 in apoptosis in human colorectal carcinoma cell lines.Mol Cell Biochem. 2016 Jan;412(1-2):297-305. doi: 10.1007/s11010-015-2636-3. Epub 2016 Jan 4. Mol Cell Biochem. 2016. PMID: 26728996
-
[Association of status of mismatch repair protein expression and EB virus infection with clinicopathological parameters in 886 gastric adenocarcinoma patients].Zhonghua Wei Chang Wai Ke Za Zhi. 2021 May 25;24(5):440-448. doi: 10.3760/cma.j.issn.441530-20200910-00518. Zhonghua Wei Chang Wai Ke Za Zhi. 2021. PMID: 34000774 Chinese.
-
Mutators Enhance Adaptive Micro-Evolution in Pathogenic Microbes.Microorganisms. 2022 Feb 15;10(2):442. doi: 10.3390/microorganisms10020442. Microorganisms. 2022. PMID: 35208897 Free PMC article. Review.
-
The role of mutators in the emergence of antibiotic-resistant bacteria.Drug Resist Updat. 2003 Jun;6(3):137-45. doi: 10.1016/s1368-7646(03)00041-4. Drug Resist Updat. 2003. PMID: 12860461 Review.
Cited by
-
Antioxidant Role of Probiotics in Inflammation-Induced Colorectal Cancer.Int J Mol Sci. 2024 Aug 20;25(16):9026. doi: 10.3390/ijms25169026. Int J Mol Sci. 2024. PMID: 39201713 Free PMC article. Review.
-
Gut Microbiota Reshapes the Tumor Microenvironment and Affects the Efficacy of Colorectal Cancer Immunotherapy.Cancer Med. 2025 Jun;14(12):e70994. doi: 10.1002/cam4.70994. Cancer Med. 2025. PMID: 40530896 Free PMC article. Review.
-
Unraveling colorectal cancer prevention: The vitamin D - gut flora - immune system nexus.World J Gastrointest Oncol. 2024 Jun 15;16(6):2394-2403. doi: 10.4251/wjgo.v16.i6.2394. World J Gastrointest Oncol. 2024. PMID: 38994172 Free PMC article. Review.
References
-
- Kilkkinen A, Rissanen H, Klaukka T. et al. Antibiotic use predicts an increased risk of cancer. Int J Cancer 2008;123:2152–5. - PubMed
-
- Wang JL, Chang CH, Lin JW. et al. Infection, antibiotic therapy and risk of colorectal cancer: a nationwide nested case-control study in patients with Type 2 diabetes mellitus. Int J Cancer 2014;135:956–67. - PubMed
-
- Boursi B, Haynes K, Mamtani R. et al. Impact of antibiotic exposure on the risk of colorectal cancer. Pharmacoepidemiol Drug Saf 2015;24:534–42. - PubMed
-
- Zhang J, Haines C, Watson AJM. et al. Oral antibiotic use and risk of colorectal cancer in the United Kingdom, 1989-2012: a matched case-control study. Gut 2019;68:1971–8. - PubMed
LinkOut - more resources
Full Text Sources